Skip to main content

Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial

Publication ,  Conference
Peters, KB; Vredenburgh, JJ; Desjardins, A; Friedman, HS; Herndon, JE; Coan, AD; McSherry, F; Lipp, ES; Brickhouse, A; Massey, WC; Reardon, DA
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2012

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2012

Volume

30

Issue

15

Location

Chicago, IL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Vredenburgh, J. J., Desjardins, A., Friedman, H. S., Herndon, J. E., Coan, A. D., … Reardon, D. A. (2012). Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
Peters, Katherine B., James J. Vredenburgh, Annick Desjardins, Henry S. Friedman, James Emmett Herndon, April D. Coan, Frances McSherry, et al. “Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Herndon JE, Coan AD, et al. Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.
Peters, Katherine B., et al. “Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 15, AMER SOC CLINICAL ONCOLOGY, 2012.
Peters KB, Vredenburgh JJ, Desjardins A, Friedman HS, Herndon JE, Coan AD, McSherry F, Lipp ES, Brickhouse A, Massey WC, Reardon DA. Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2012

Volume

30

Issue

15

Location

Chicago, IL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences